• 1
    Andrykowski MA, Carpenter JS, Studts JL, et al. Psychological impact of benign breast biopsy: a longitudinal, comparative study. Health Psychol. 2002; 21: 485494.
  • 2
    Coyne JC, Palmer SC, Shapiro PJ, Thompson R, DeMichele A. Distress, psychiatric morbidity, and prescriptions for psychotropic medication in a breast cancer waiting room sample. Gen Hosp Psychiatry. 2004; 26: 121128.
  • 3
    Epping-Jordan JE, Compas BE, Osowiecki DM, et al. Psychological adjustment in breast cancer: processes of emotional distress. Health Psychol. 1999: 18: 315326.
  • 4
    Kornblith AB, Herndon JEII, Weiss RB, et al. Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer. 2003; 98: 679689.
  • 5
    Luecken LJ, Compas BE. Stress, coping, and immune function in breast cancer. Ann Behav Med. 2002; 24: 336344.
  • 6
    Ahles TA, Saykin AJ, Furstenberg CT, et al. Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy. J Clin Oncol. 2005; 23: 43994405.
  • 7
    Holland JC. Update: NCCN practice guidelines for the management of psychosocial distress. Oncology. 1999; 13: 459507.
  • 8
    Amir M, Ramati A. Post-traumatic symptoms, emotional distress and quality of life in long-term survivors of breast cancer: a preliminary research. J Anxiety Disord. 2002; 16: 195206.
  • 9
    Holland JC. American Cancer Society Award lecture. Psychological care of patients: psycho-oncology's contribution. J Clin Oncol. 2003; 21( 23 suppl): 253s-265s.
  • 10
    Kangas M, Henry JL, Bryant RA. Posttraumatic stress disorder following cancer. A conceptual and empirical review. Clin Psychol Rev. 2002; 22: 499524.
  • 11
    Smith MY, Redd WH, Peyser C, Vogl D. Post-traumatic stress disorder in cancer: a review. Psychooncology. 1999; 8: 521537.
  • 12
    Ganz PA, Kwan L, Stanton AL, et al. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst 2004; 96: 376387.
  • 13
    Koopman C, Angell K, Turner-Cobb JM, et al. Distress, coping, and social support among rural women recently diagnosed with primary breast cancer. Breast J. 2001; 7: 2533.
  • 14
    Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 2001; 84: 10111015.
  • 15
    American Psychosocial Oncology Society. APOS standards of care for the management of distress in patients with cancer. Charlottesville, VA: American Psychosocial Oncology Society, 2000.
  • 16
    Holland JC, Jacobsen PB, Riba MB. NCCN: Distress management. Cancer Control. 2001; 8(6 supp 2): 8893.
  • 17
    Fawzy FI, Fawzy NW. Group therapy in the cancer setting. J Psychosom Res. 1998; 45: 191200.
  • 18
    Brody DS, Khaliq AA, Thompson TL. Patients' perspectives on the management of emotional distress in primary care settings. J Gen Intern Med. 1997; 12: 403406.
  • 19
    Roeloffs C, Sherbourne C, Unutzer J, Fink A, Tang L, Wells KB. Stigma and depression among primary care patients. Gen Hosp Psychiatry. 2003; 25: 311315.
  • 20
    Greer S. Healing the mind/body split: bringing the patient back into oncology. Integr Cancer Ther. 2003; 2: 512.
  • 21
    Mager WM, Andrykowski MA. Communication in the cancer ‘bad news’ consultation: patient perceptions and psychological adjustment. Psychooncology. 2002; 11: 3546.
  • 22
    Pirl WF, Roth AJ. Diagnosis and treatment of depression in cancer patients. Oncology. 1999; 13: 12931306.
  • 23
    Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma. Cancer. 1998; 82: 19041908.
  • 24
    Payne DK, Hoffman RG, Theodoulou M, Dosik M, Massie MJ. Screening for anxiety and depression in women with breast cancer: psychiatry and medical oncology gear up for managed care. Psychosom. 1999; 40: 6469.
  • 25
    Holland JC. An algorithm for rapid assessment and referral of distressed patients. In: Perry CM, ed. American Society of Clinical Oncology 2000 educational book. Thirty-sixth annual meeting, May 19–23, 2000, New Orleans, LA. Alexandria, Va: American Society of Clinical Oncology; 2000: 129138.
  • 26
    Spitzer RL, Kroenke K, Williams JBW. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999; 282: 17371744.
  • 27
    American Psychiatric Association diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
  • 28
    Spitzer R, Williams J, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 Study. JAMA. 1994; 14: 17491756.
  • 29
    Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606613.
  • 30
    Martin A, Rief W, Klaiberg A, Braehler E. Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population. Gen Hosp Psychiatry. 2006; 28: 7177.
  • 31
    Prins A, Ouimette P, Kimerling R, et al. The primary care PTSD screen (PC-PTSD): development and operating characteristics. Prim Care Comm Psychiatry. 2004; 9: 914.
  • 32
    Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM. ( 1993, October) The PTSD Checklist (PCL): Reliability, validity, and diagnostic utility. In: International Society of Traumatic Stress. San Antonio, Texas.
  • 33
    Blake D, Weathers F, Nagy L, et al. Clinician Administered PTSD Scale (CAPS). Washington, DC: US Department of Veterans Affairs. National Center for PTSD Materials; 1990. Available from URL:
  • 34
    Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1994; 252: 19051907.
  • 35
    Wells K, Stewart A, Hays R, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA. 1989; 262: 914919.
  • 36
    Ware JE, Kosinski M. SF-36 physical and mental health summary scales: a manual for users of version 1. 2nd ed. Lincoln, RI: Quality Metric Incorporated; 2001.
  • 37
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new me thod of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373383.
  • 38
    Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996; 34: 7384.